Todd Brady, Aldeyra Therapeutics CEO
To sNDA or NDA? Aldeyra clears a second PhIII for seasonal allergy eye drop
Aldeyra said its eye drop was better than the comparator at reducing ocular itching, redness and tearing, which means it has now cleared two Phase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
